Accessibility Menu
Weed logo

Weed

(OTC) BUDZ

Current Price$0.03
Market Cap$3.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-83%
5 Year-93%
1 Year-8%
1 Month-6%
Weed last closing stock price
MetricPriceDate
Last closeUSD 0.032026-07-17
Weed stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10.89%USD 0.032026-07-10
1 month-6.01%USD 0.032026-06-17
3 month+9%USD 0.022026-04-17
Year to date-40.44%USD 0.042025-12-31
1 year-8.36%USD 0.032025-07-17
3 year-66.56%USD 0.082023-07-18
5 year-92.86%USD 0.362021-07-16
Since inception-82.83%USD 0.152015-02-03

Weed Financials at a Glance

Market Cap

$3.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$1.11M

EPS (TTM)

-$0.01

P/E Ratio

-3.22

Dividend

$0.00

Beta (Volatility)

0.16 (Low)

Price

$0.03

Volume

6,404

Open

$0.02

Previous Close

$0.03

Daily Range

$0.02 - $0.03

52-Week Range

$0.02 - $0.08

Estimated Earnings Date

May 15, 2026

BUDZ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Weed

WEED develops cannabis-based compounds for medical and industrial uses. Its research aims to create new plant strains for future therapies. The company also manages real estate and digital asset projects in the cannabis sector.

What’s in the WEED Toolbox?

  • Cannabis Genomic Research: Studies cannabis DNA to develop new plant strains for medical and industrial use (0% of revenue).
  • Proprietary Seedbank: Maintains over 250 cannabis and hemp strains, including rare varieties, for future breeding (0% of revenue).
  • Real Estate Holdings: Owns the Four Winds of Lake Erie property, intended for hemp cultivation and beverage production (0% of revenue).
  • Industrial Hemp Licensing: Holds licenses in Arizona for hemp cultivation, nursery, and processing (0% of revenue).
  • Digital Asset Initiatives: Early-stage development of digital tokens (WEEDCoin, BUDZCoin) to address banking and supply chain issues (0% of revenue).

Growth and Expansion: The WEED Way

  • Acquired Hempirical Genetics, LLC in 2022, expanding its proprietary seedbank.
  • Formed a strategic partnership with Remergify, Inc. in December 2025 to develop digital asset solutions.
  • Integrated HEMP BioSciences Inc. for industrial hemp licensing and compliance in Arizona.
  • Streamlined operations by deregistering WEED Hong Kong Ltd. and WEED Australia Ltd. in 2025.
  • Maintained and marketed the Four Winds of Lake Erie property for future hemp and beverage market entry.

What Makes WEED Stand Out?

WEED focuses on cannabis genomic research, aiming to create patentable plant strains. Its asset base includes real estate and a large seedbank. The company also explores digital solutions for industry-specific banking challenges.

Five Things You Need to Know

  • No revenue reported for 2025 or previous years; all segments are pre-commercial.
  • Operating loss was $1.33 million in 2025, up 150.5% from 2024.
  • Cash on hand was $33,130 at December 31, 2025, down 79.2% from 2024.
  • Total liabilities reached $1.25 million in 2025, up 30.1% from 2024.
  • Company has two full-time employees and a market cap of $2.83 million as of March 2026.

Bottom Line

WEED remains a research-focused company with no commercial sales to date. Its future depends on continued funding and successful development of cannabis-based innovations.

AI Generated • Apr 16, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

2

CEO

Glenn E. Martin

Website

www.weedincusa.com

Headquarters

Tucson, AZ 85750, US

BUDZ Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

177.63%

Return on Capital

N/A

Return on Assets

-214.66%

Earnings Yield

-31.06%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

148.31M

Volume

6.40K

Avg. Volume

52.52K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$1.06M

EBITDA

-$1.04M

Operating Cash Flow

-$181.04K

Capital Expenditure

-$3.00

Free Cash Flow

-$181.04K

Cash & ST Invst.

$1.80K

Total Debt

$536.27K

Weed Performance Analysis

Weed annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Weed sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Weed annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.01-48.6%
20232023-12-31USD -0.00-97.6%
20242024-12-31USD -0.001266.7%
20252025-12-31USD -0.01146.3%
Weed sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3075.8%
Q32025-09-30-25.0%
Q42025-12-31-450.0%
Q12026-03-3178.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$5.62K

+0.0%

Gross Margin

0.00%

N/A

Market Cap

$3.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.91M

N/A

Employees

2

N/A

Net Income

-$175.26K

+60.2%

EBITDA

-$158.33K

+63.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$1.80K

-42.9%

Total Debt

$536.27K

+50.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$537.79K

+51.0%

Return on Assets

-2.15%

N/A

Return on Invested Capital

1.26%

N/A

Free Cash Flow

-$57.74K

+19.6%

Operating Cash Flow

-$57.74K

+19.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CVSICV Sciences, Inc.
$0.02-10.00%
DHBUFDelivra Health Brands Inc.
$0.08+8.55%
BBRRFBlueberries Medical Corp.
$0.01+0.00%
CBIHCannabis Bioscience International Holdings, Inc.
$0.00-50.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ZYBTZhengye Biotechnology
$8.01+10.48%
AALAmerican Airlines Group
$15.14+0.01%
ACHRArcher Aviation
$5.31+0.20%
IRENIren
$40.20+0.20%

Questions About BUDZ

What is the current price of Weed?

Weed is trading at $0.03 per share.

What is the 52-week range for Weed?

Over the past 52 weeks, Weed has traded between $0.02 and $0.08.

How much debt does Weed have?

As of the most recent reporting period, Weed reported total debt of $536.27K.

How much cash does Weed have on hand?

Weed reported $1.80K in cash and cash equivalents in its most recent financial results.

What is Weed’s dividend yield?

Weed does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services